Overview
- 3 inspections across 3 sites are on record.
- 4 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-11-17.
At a glance
Inspections
3
Sites
3
Observations
4
Career since
Nov 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Shanghai Desano Chemical Pharmaceutical Co., Ltd | 17 Nov 2023 | Human Drugs | On file |
| Glaxo Operations UK Ltd | 4 Nov 2022 | Human Drugs | |
| Allermed Laboratories, Inc. | 12 Nov 2018 | Biologics | View 483 → |
Sites inspected
Shanghai Desano Chemical Pharmaceutical Co., LtdPudong District, China1 insp.
Glaxo Operations UK LtdWare, United Kingdom1 insp.
Allermed Laboratories, Inc.San Diego, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Nadeem I Chaudhry1 shared
Feiyan Jin1 shared
Sharmista Chatterjee1 shared
Ileana Barreto-Pettit1 shared
Arie Menachem1 shared
Full investigator report
Get the verbatim findings behind Colleen F Hoyt's 4 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site